Skip to main content
Ambrosia Ventures
Deal Intelligence Blog

Insights for Deal Professionals

Data-driven analysis backed by 1,400+ primary-sourced biopharma transactions. Licensing benchmarks, negotiation strategies, and market intelligence.

FeaturedMarket Trend

Immunology Deals Up 1167% in 2026 — Here's the Data

Immunology deal activity jumped from 3 transactions to 38 in just six months — a 1167% increase that signals a fundamental shift in Big Pharma portfolio strategy. We break down the deals, the drivers, and what BD teams should do right now.

5 min read
Read article

Market Trend articles · page 1 of 9

Benchmark Your Next Deal

Get data-driven deal terms for any therapeutic area, modality, and clinical phase. Powered by 1,400+ primary-sourced biopharma transactions.

Try Solidus